Ali Behbahani

(Dr. Ali Behbahani M.D.)

Currently holds positions in CRISPR Therapeutics AG, Genocea Biosciences Inc and Adaptimmune Therapeutics PLC

Positions

Position Company Period
Independent Director CRISPR Therapeutics AG April 1, 2015 -
Independent Director Genocea Biosciences Inc Feb. 8, 2018 -
Non-Executive Independent Director Adaptimmune Therapeutics PLC Sept. 1, 2014 -
Independent Director Nevro Corp Sept. 1, 2014 - March 19, 2019
Ali Behbahani's trades of MBX Biosciences Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-09-17 2024-09-16
B Purchase
500,000 +16.1%
16.00
USD 8,000,000 		500,000 +16.1% 16.00 USD 8,000,000
2023-07-19 2023-07-17
US Savara Inc (SVRA)
B Purchase
333,333 +1.4%
3.00
USD 999,999 		333,333 +1.4% 3.00 USD 999,999
2023-07-06 2023-07-05
B Purchase
1,000,000 +29.0%
5.00
USD 5,000,000 		1,000,000 +29.0% 5.00 USD 5,000,000
2022-05-26 2022-05-25
S Sale
4,445,093 -100.0%
0.08
USD 362,720 		4,445,093 -100.0% 0.08 USD 362,720
2022-05-26 2022-05-24
S Sale
5,931,843 -57.2%
0.07
USD 387,943 		5,931,843 -57.2% 0.07 USD 387,943
2022-04-13 2022-04-11
B Purchase
948,948 +inf%
1.90
USD 1,803,001 		948,948 +inf% 1.90 USD 1,803,001
2022-04-13 2022-04-11
B Purchase
2,631,578 +33.8%
1.90
USD 4,999,998 		2,631,578 +33.8% 1.90 USD 4,999,998
2021-10-19 2021-10-18
B Purchase
1,851,852
0.00
USD 0 		1,851,852 0.00 USD 0
2021-03-18 2021-03-16
B Purchase
5,714,285 +114.3%
1.75
USD 9,999,999 		5,714,285 +114.3% 1.75 USD 9,999,999
2020-12-07 2020-12-04
B Purchase
4,398,602 +214.3%
0.62
USD 2,735,930 		4,398,602 +214.3% 0.62 USD 2,735,930
2020-09-22 2020-09-18
B Purchase
769,230 +33.6%
13.00
USD 9,999,990 		769,230 +33.6% 13.00 USD 9,999,990
2020-07-28 2020-07-24
B Purchase
3,151,260 +43.6%
2.25
USD 7,090,335 		3,151,260 +43.6% 2.25 USD 7,090,335
2020-07-01 2020-06-30
US Akouos Inc (AKUS)
B Purchase
588,235 +15.9%
17.00
USD 9,999,995 		588,235 +15.9% 17.00 USD 9,999,995
2020-04-13 2020-04-03
S Sale
564 -0.0%
2.66
USD 1,500 		564 -0.0% 2.66 USD 1,500
2020-02-05 2020-02-03
B Purchase
800,000 +30.2%
19.00
USD 15,200,000 		800,000 +30.2% 19.00 USD 15,200,000
2020-01-28 2020-01-24
B Purchase
7,500,000 +62.5%
0.67
USD 5,000,250 		7,500,000 +62.5% 0.67 USD 5,000,250
2019-07-24 2019-07-22
B Purchase
450,000 +12.0%
15.00
USD 6,750,000 		450,000 +12.0% 15.00 USD 6,750,000
2019-06-25 2019-06-24
B Purchase
2,857,142 +65.4%
3.50
USD 9,999,997 		2,857,142 +65.4% 3.50 USD 9,999,997
2019-05-13 2019-05-09
B Purchase
1,500,000 +51.0%
10.00
USD 15,000,000 		1,500,000 +51.0% 10.00 USD 15,000,000
2019-05-13 2019-05-09
B Purchase
1,000,000 +51.6%
10.00
USD 10,000,000 		1,000,000 +51.6% 10.00 USD 10,000,000
2019-05-09 2019-05-07
B Purchase
1,136,704 +124.1%
1.08
USD 1,227,640 		1,136,704 +124.1% 1.08 USD 1,227,640
2019-02-19 2019-02-14
B Purchase
9,948,269 +39.8%
0.47
USD 4,688,619 		9,948,269 +39.8% 0.47 USD 4,688,619
// ... existing code ... // ... rest of the file ...